Literature DB >> 19649996

Is it possible to use standard electrocardiography for risk assessment of patients with pulmonary embolism?

Maciej Kostrubiec1, Anna Hrynkiewicz, Justyna Pedowska-Włoszek, Szymon Pacho, Michał Ciurzyński, Krzysztof Jankowski, Magdalena Koczaj-Bremer, Artur Wojciechowski, Piotr Pruszczyk.   

Abstract

BACKGROUND: Risk stratification of patients with acute pulmonary embolism (APE) is crucial for appropriate treatment selection. Shock and hypotonia are known indications for aggressive management. However, in the haemodynamically stable group the best prognosis strategy is still being sought. Acute pulmonary embolism often provokes changes in electrocardiography recordings (ECG). AIM: To assess whether ECG features recorded on admission can be useful for risk stratification during hospitalisation.
METHODS: We analysed 12-lead ECG and echocardiography of 56 patients (22 males, age: 64.3 +/- 17.9 years) with diagnosed APE. The diagnosis of APE was confirmed by spiral computer tomography. The ECG analysis was based on the 21-point ECG score including: the presence of tachycardia (> 100 beats/min), right bundle branch block, negative S waves in lead I, negative Q or T waves in lead III, S1Q3T3 complex and depth of negative T waves in leads V1-V4. ECG features were scored from 0 to 21 points. Complicated in-hospital course was defined as need for vasopressor, thrombolysis, embolectomy or resuscitation and the presence of shock index > 1 (heart rate/systolic blood pressure).
RESULTS: Four (7.1%) patients died during hospitalisation and in 8 (14.3%) others complications occurred. Patients with complications had higher mean sum of 21-ECG score compared to subjects with uneventful course [8 (1-17) vs. 3 (0-18); p = 0.04]. Right ventricular contractility dysfunction (RVD) in echocardiography was found in 13 (23.2%) patients, who had higher ECG score compared to patients without RVD [8 (3-17) vs. 2 (0-18); p = 0.004]. The area under the ROC curve to assess the usefulness of 21-ECG score to predict RVD was 0.794 (95% CI 0.665-0.891) and for PPH 0.727 (95% CI 0.591-0.837). The sensitivity and specificity, positive and negative predictive value for the value > 3 points in 21-ECG score to predict RVD were: 92, 65, 44, 97% and for PPH: 75, 46, 19, 92%, respectively.
CONCLUSIONS: 21-ECG score is a simple and cheap method which can be used to predict RVD and serious complications in patients with APE. A value Ł 3 points in the 21-ECG score can exclude RVD with high probability and limit the need of echocardiography to 23% of haemodynamically stable patients.

Entities:  

Mesh:

Year:  2009        PMID: 19649996

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  6 in total

Review 1.  The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: a consensus paper.

Authors:  Geneviève C Digby; Piotr Kukla; Zhong-Qun Zhan; Carlos A Pastore; Ryszard Piotrowicz; Edgardo Schapachnik; Wojciech Zareba; Antonio Bayés de Luna; Piotr Pruszczyk; Adrian M Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-05       Impact factor: 1.468

2.  ECG In Evaluation for Pulmonary Thromboembolism- Occam's Razor or Hickam's Dictum?

Authors:  Ram V Nampoothiri; Arjun Lakshman; Ashish Bhalla; Subhash Varma
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 3.  The value of electrocardiography in prognosticating clinical deterioration and mortality in acute pulmonary embolism: A systematic review and meta-analysis.

Authors:  Amro Qaddoura; Geneviève C Digby; Conrad Kabali; Piotr Kukla; Zhong-Qun Zhan; Adrian M Baranchuk
Journal:  Clin Cardiol       Date:  2017-06-19       Impact factor: 2.882

Review 4.  Findings From 12-lead Electrocardiography That Predict Circulatory Shock From Pulmonary Embolism: Systematic Review and Meta-analysis.

Authors:  Jacob D Shopp; Lauren K Stewart; Thomas W Emmett; Jeffrey A Kline
Journal:  Acad Emerg Med       Date:  2015-09-22       Impact factor: 3.451

5.  The role of ST-segment elevation in lead aVR in the risk assessment of patients with acute pulmonary embolism.

Authors:  Karin Janata; Thomas Höchtl; Catharina Wenzel; Rudolf Jarai; Barbara Fellner; Alexander Geppert; Peter Smetana; Vera Havranek; Kurt Huber
Journal:  Clin Res Cardiol       Date:  2011-12-22       Impact factor: 5.460

6.  Clinical Significance of ST Elevation in Lead aVR in Acute Pulmonary Embolism.

Authors:  Leili Pourafkari; Samad Ghaffari; Arezou Tajlil; Fariborz Akbarzadeh; Farin Jamali; Nader D Nader
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-05-25       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.